Papers written by Patrick Stahly

  1. Stahly, G. P. Crystal Growth & Design 2007, 7, 1007-1026. Diversity in Single-and Multiple-Component Crystals. The Search for and Prevalence of Polymorphs and Cocrystals.
  2. Childs, S. L.; Stahly, G. P.; Park, A. Molecular Pharmaceutics 2007, 4, 323-338. Salts and Cocrystals of Theophylline.
  3. Stahly, G. P. Journal of Pharmaceutical Science and Technology, Japan 2006, 66, 435-439. The Importance of Salt Selection and Polymorph Screening for the Drug Product.
  4. Stahly, G. P.; Bates, S.; Andres, M. A.; Cowans, B. A. Crystal Growth & Design 2006, 6, 925-932. Discovery of a New Polymorph of Dehydroepiandrosterone (Prasterone) and Solution of Its Crystal Structure for X-ray Powder Diffraction Data.
  5. Childs, S. L.; Chyall, L. J.; Dunlap, J. T.; Smolenskaya, V. N.; Stahly, B. C.; Stahly, G. P. J. Am. Chem. Soc. 2004, 126, 13335-13342. Crystal Engineering Approach to Forming Cocrystals of Amine Hydrochloride with Organic Acids. Molecular Complexes of Fluoxetine Hydrochloride with Benzoic, Succinic, and Fumaric Acids.
  6. Childs, S. L.; Chyall, L. J.; Dunlap, J. T.; Coates, D. A.; Stahly, B. C.; Stahly, G. P. Crystal Growth & Design 2004, 4, 441-449. A Metastable Polymorph of Metformin Hydrochloride: Isolation and Characterization Using Capillary Crystallization and Thermal Microscopy Techniques.
  7. Newman, A.W.; Stahly, G.P. in Handbook of Pharmaceutical Analysis; Ohannesian, L.; Streeter, A.J., Eds.; Drugs and the Pharmaceutical Sciences Series 117; Marcel Dekker: New York, 2001, Chapter 1. Form Selection of Pharmaceutical Compounds.
  8. He, X.; Stowell, J.G.; Morris, K.R.; Pfeiffer, R.R.; Li, H.; Stahly, G.P.; Byrn, S.R. Crystal Growth & Design 2001, 1, 305-312. Stabilization of a Metastable Polymorph of 4-Methyl-1,2-nitroacetanilide by Isomorphic Additives.
  9. Stahly, G.P.; Byrn, S.R. in Molecular Modeling Applications in Crystallization; Myerson, A.S., Ed.; Cambridge University Press: New York, 1999, Chapter 6. The Solid-State Structure of Chiral Organic Pharmaceuticals.
  10. Stahly, G.P.; McKenzie, A.T.; Andres, M.C.; Russell, C.A.; Byrn, S.R.; Johnson, P. J. Pharm. Sci. 1997, 86, 970-971. Determination of the Optical Purity of Ibuprofen Using X-ray Powder Diffraction.
  11. Stahly, G.P.; Starrett, R.M. in Chirality in Industry II; Collins, A. N.; Sheldrake, G. N.; Crosby, J., Eds.; Wiley & Sons: New York, 1997, Chapter 3. Production Methods for Chiral Non-steroidal Anti-inflammatory Profen Drugs.
  12. Wu, F. J.; Stahly, G. P.; Fronczek, F. R.; Watkins, S. F. Acta Crystallogr. 1995, C51, 18-20. The Structure of 1,4,7-Tri-n-butyl-1,4,7-triazacyclononanechromium Trichloride.
  13. Manimaran, T.; Stahly, G.P. Tetrahedron: Asymmetry 1993, 4, 1949-1954. Optical Purification of Profen Drugs.
  14. Manimaran, T.; Wu, T-C.; Klobucar, W.D.; Kolich, C.H.; Stahly, G.P.; Fronczek, F.R.; Watkins, S.E. Organometallics 1993, 12, 1467-1470. In-situ Generation of Ruthenium Chiral Phosphine Complexes and Their Use in Asymmetric Hydrogenation.
  15. Stahly, G.P. Today's Chemist at Work 1993, 2, 28. TLC: An Often Overlooked Tool Giving Speed and Convenience at Low Cost.
  16. Stahly, G.P.; Jackson, A. J. Org. Chem. 1991, 56, 5472-5475. Synthesis of 2-(Perfluoroalkylphenyl)propionic Acids.
  17. Stahly, G.P. J. Fluorine Chem. 1989, 45, 431-433. Trifluoromethylation of 1,3,5-Trinitrobenzene.
  18. Stahly, G.P.; Bell, D.R. J. Org. Chem. 1989, 54, 2873-2877. A New Method for Synthesis of Trifluoromethyl-Substituted Phenols and Anilines.
  19. Stahly, G.P. J. Fluorine Chem. 1989, 43, 53-66. Nucleophilic Addition of Difluoromethyl Phenyl Sulfone to Aldehydes and Various Transformations of the Resulting Alcohols.
  20. Stahly, G.P.; Stahly, B.C.; Maloney, J.R. J. Org. Chem. 1988, 53, 690-692. Base-Induced Reactions of Polynitroarenes with Methyl 2-Chloropropionate.
  21. Stahly, G.P. Synth. Commun. 1987, 17, 1053-1062. A Diels-Alder Approach to 4,4'-Thiobis(phthalic acid) Derivatives.
  22. Stahly, G.P. J. Org. Chem. 1985, 50, 3091-3094. Synthesis of Unsymmetrical Biphenyls by Reaction of Nitroarenes with Phenols.
  23. Stahly, G.P.; Stahly, B.C.; Lilje, K.C. J. Org. Chem. 1984, 49, 578-579. Synthesis of 2-(4-Nitroaryl)propionate Esters.
  24. Stahly, G.P.; Marlett, E.M.; Nelson, G.E. J. Org. Chem. 1983, 48, 4423-4426. Selective Hydrolysis-Decarboxylation of Ethyl 1,4-Dimethyl-3-(ethoxycarbonyl)-1H-pyrrole-2-acetate.
  25. Jarvis, B.B.; Stahly, G.P.; Pavanasasivam, G.; Midiwo, J.O.; DeSilva, T.; Holmlund, C.E.; Mazzola, E.P.; Geoghegan, R.F. J. Org. Chem. 1982, 47, 1117-1124. Isolation and Characterization of the Trichoverroids and New Roridins and Verrucarins.
  26. Jarvis, B.B.; Pavanasasivam, G.; Holmlund, C.E.; DeSilva, T.; Stahly, G.P.; Mazzola, E.P. J. Am. Chem. Soc. 1981, 103, 472-474. Biosynthetic Intermediates to the Macrocyclic Trichothecenes.
  27. Jarvis B.B.; Stahly, G.P. J. Org. Chem. 1980, 45, 2604-2609. Reactions of 2,3-Diphenylthiirene 1,1-Dioxide with Nucleophiles.
  28. Jarvis, B.B.; Stahly, G.P.; Pavanasasivam, G.; Mazzola, E.P. J. Med. Chem. 1980, 23, 1054-1058. Antileukemic Compounds Derived from the Chemical Modification of Macrocyclic Trichothecenes. 1. Derivatives of Verrucarin A.
  29. Stahly, G.P.; Ammon, H.L.; Jarvis, B.B. Acta Cryst. 1980, B36, 2159-2162. The Structure of 4-[(E)-1,2-Diphenylvinyl]-2,6-diphenyl-1,3,4,5-thiatriazine 1,1-Dioxide.
  30. Jarvis, B.B.; Midiwo, J.O.; Stahly, G.P.; Pavanasasivam, G.; Mazzola, E.P. Tetrahedron Lett. 1980, 787-788. Trichodermadiene: A New Novel Trichothecene.
  31. Jarvis, B.B.; Stahly, G.P.; Pavanasasivam, G.; Mazzola, E.P. J. Antibiotics 1980, 33, 256-258. Structure of Roridin J, A New Macrocyclic Trichothecene from Myrothecium Verrucaria.
  32. Jarvis, B.B.; Stahly, G.P.; Ammon, H.L. Tetrahedron Lett. 1978, 3781-3784. A Novel New Heterocycle from the Reaction of Azide Ion with 2,3-Diphenylthiirene 1,1-Dioxide.
  33. Jarvis, B.B.; Stahly, G.P.; Curtis, C.R. Cancer Treat. Rep. 1978, 62, 1585-1586. Antitumor Activity of Fungal Metabolites: Verrucarin Beta-9,10-epoxides.
Chemfocus © 2007-2009 | Sitemap